Head-to-head · Cost-Efficiency Index
Found vs GetRelief Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Cost-first shoppers who also want behavior-change coaching bundled with the medication.
Visit FoundGetRelief Rx
Cost-first shoppers who want sublingual (non-injectable) compounded GLP-1 drops for the needle-averse.
Visit GetRelief RxThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 61. The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle. GetRelief Rx still earns a C — Cost-first shoppers who want sublingual (non-injectable) compounded GLP-1 drops for the needle-averse.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | GetRelief Rx |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 61/100 |
| Semaglutide / mo | $129/mo | $269/mo (9 mg dose, compounded oral) |
| Tirzepatide / mo | $129/mo | $179/mo (16 mg dose, compounded oral) |
| Semaglutide / yr (modeled) | $1,548 | $3,228 |
| Tirzepatide / yr (modeled) | $1,548 | $2,148 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank on the board | #7 | #222 |
Found
88/100Where the value is
- Lowest cost-per-month on the board — identical $129 on both molecules
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- Coaching subscription can't be unbundled, which reduces contract flexibility
- Compounded only
GetRelief Rx
61/100Where the value is
- Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
- BBB accredited with an A rating (March 2026)
- Free online assessment with no upfront consultation fee
The tradeoffs
- Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
- Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.